Vasculitides associated with malignancies: Analysis of sixty patients

Abstract

Objective. To describe characteristics and outcomes of vasculitides associated with malignancies. Methods. The requirement for inclusion in this retrospective, 10-year study was development of vasculitis in patients with a progressing malignancy. Malignancies secondary to immunosuppressants used to treat vasculitis were excluded. The main characteristics of vasculitides were analyzed and compared according to the type of malignancy.

Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review

“…Previous studies described SAIDs in patients with MDS, but CMML was rarely included (7,8,14,15). Only one series of 8 cases of medium-vessel vasculitis associated with CMML was reported, with SAIDs diagnosed after CMML, and a fatal course in 7 cases (7).…”

Henoch-Schönlein purpura associated with a neuroblastoma: Report of one case and a review of the literature

“…The relationship between vasculitis and malignancy remains unclear: e.g. fortuitous association, paraneoplastic syndrome, or neoplasms induced by immunosuppressive drugs prescribed to treat vasculitis, and so on (25). HSP is an allergic vasculitis disease caused by an immunologic mechanism (26)(27)(28)(29).…”

Acute Lymphoblastic Leukemia in Systemic Lupus Erythematosus Disguise: A Case Report

“…Cutaneous Leukocytoclastic Vasculitis is the most common type of vasculitis reported with cancer, especially the myeloproliferative and lymphoproliferative hematologic malignancies [7]. Fain, et al evaluated 60 patients with vasculitis and malignancy, LCV was encountered in 45% of cases in their cohort [8].…”